Showing 1 - 10 results of 10 for search '"ГЕНЫ-СУПРЕССОРЫ ОПУХОЛЕВОГО РОСТА"', query time: 0.50s Refine Results
  1. 1
    Academic Journal

    Source: Medical Genetics; Том 21, № 7 (2022); 63-65 ; Медицинская генетика; Том 21, № 7 (2022); 63-65 ; 2073-7998

    File Description: application/pdf

    Relation: https://www.medgen-journal.ru/jour/article/view/2120/1587; Каприн А.Д., Старинский В.В., Шахзадова А.О. Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена, филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2021. 252 с.; Zhang Y., Cao L., Nguyen D., Lu H. TP53 mutations in epithelial ovarian cancer. Translational Cancer Research. 2016 Dec; 5(6): 650-663.; Aubrey B.J., Strasser A., Kelly G.L. Tumor-Suppressor Functions of the TP53 Pathway. Cold Spring Harb Perspect Med. 2016 May; 6(5): a026062.; Eskandari-Nasab E., Hashemi M., Amininia S., Ebrahimi M., Rezaei M., Mehdi Hashemi S. Effect of TP53 16-bp and β-TrCP 9-bp INS/DEL polymorphisms in relation to risk of breast cancer. Gene. 2015 Sep; 568(2): 181-5.; Hao W., Xu X., Shi H., Zhang C., Chen X. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation. European Journal of Medical Research. 2018 Oct; 23(1): 47.; Morten B., Chiu S., Oldmeadow C., Lubinski J., Scott R., Avery-Kiejda K. The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer. Breast Cancer Research and Treatment. 2019 Feb; 173(3): 727-733.

  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10